{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:04:40Z","timestamp":1790075080964,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013733","name":"Ipsen Biopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001254","name":"Ipsen Ltd UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001254","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013117","name":"International Fibrodysplasia Ossificans Progressiva Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013117","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.bone.2022.116642","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T20:17:32Z","timestamp":1670962652000},"page":"116642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The Fibrodysplasia Ossificans Progressiva Physical Function Questionnaire (FOP-PFQ): A patient-reported, disease-specific measure"],"prefix":"10.1016","volume":"168","author":[{"given":"Robert J.","family":"Pignolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Kimel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane K.","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Artyomenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick S.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2022.116642_bb0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13023-017-0674-5","article-title":"Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases","volume":"12","author":"Baujat","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bone.2022.116642_bb0010","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1302\/0301-620X.64B1.7068725","article-title":"Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients","volume":"64","author":"Connor","year":"1982","journal-title":"J. Bone Joint Surg. (Br.)"},{"key":"10.1016\/j.bone.2022.116642_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.29245\/2572-9411\/2020\/2.1196","article-title":"Epidemiology of the global fibrodysplasia ossificans progressiva (FOP) community","volume":"5","author":"Liljesthr\u00f6m","year":"2020","journal-title":"J. Rare Dis. Res. Treat."},{"key":"10.1016\/j.bone.2022.116642_bb0020","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jbmr.2728","article-title":"The natural history of flare-ups in fibrodysplasia ossificans progressiva (FOP): a comprehensive global assessment","volume":"31","author":"Pignolo","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2022.116642_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2019.115116","article-title":"Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva","volume":"130","author":"Towler","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bone.2022.116642_bb0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1750-1172-6-80","article-title":"Fibrodysplasia ossificans progressiva: clinical and genetic aspects","volume":"6","author":"Pignolo","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bone.2022.116642_bb0035","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2106\/00004623-199302000-00009","article-title":"The histopathology of fibrodysplasia ossificans progressiva. An endochondral process","volume":"75","author":"Kaplan","year":"1993","journal-title":"JBJS"},{"key":"10.1016\/j.bone.2022.116642_bb0040","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jbmr.1473","article-title":"Fibrodysplasia ossificans progressiva: middle-age onset of heterotopic ossification from a unique missense mutation (c.974G>C, p.G325A) in ACVR1","volume":"27","author":"Whyte","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2022.116642_bb0045","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2106\/JBJS.I.00705","article-title":"Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva","volume":"92","author":"Kaplan","year":"2010","journal-title":"JBJS"},{"key":"10.1016\/j.bone.2022.116642_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115274","article-title":"Self-reported baseline phenotypes from the international fibrodysplasia ossificans progressiva (FOP) association global registry","volume":"134","author":"Pignolo","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bone.2022.116642_bb0055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.29245\/2572-9411\/2021\/1.1200","article-title":"Caregiver support in fibrodysplasia ossificans progressiva","volume":"6","author":"Al Mukaddam","year":"2021","journal-title":"J. Rare Dis. Res. Treat."},{"key":"10.1016\/j.bone.2022.116642_bb0060","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13023-019-1068-7","article-title":"Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes","volume":"14","author":"Pignolo","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bone.2022.116642_bb0065","first-page":"1","article-title":"The medical management of fibrodysplasia ossificans progressiva: current treatment considerations","volume":"1","author":"Kaplan","year":"2019","journal-title":"Proc. Int. Clin. Counc. FOP"},{"key":"10.1016\/j.bone.2022.116642_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13023-018-0810-x","article-title":"Patient reported outcome measures in rare diseases: a narrative review","volume":"13","author":"Slade","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bone.2022.116642_bb0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13023-018-0958-4","article-title":"Illustration of patient-reported outcome challenges and solutions in rare diseases: a systematic review in Cushing\u2019s syndrome","volume":"13","author":"Knoble","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bone.2022.116642_bb0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13023-017-0718-x","article-title":"Measuring what matters to rare disease patients \u2013 reflections on the work by the IRDiRC taskforce on patient-centered outcome measures","volume":"12","author":"Morel","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bone.2022.116642_bb0100","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/art.20820","article-title":"Revised versions of the childhood health assessment questionnaire (CHAQ) are more sensitive and suffer less from a ceiling effect","volume":"51","author":"Lam","year":"2004","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.bone.2022.116642_bb0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bone.2017.08.032","article-title":"The FOP connection registry: design of an international patient-sponsored registry for fibrodysplasia ossificans progressiva","volume":"109","author":"Mantick","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bone.2022.116642_bb0110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bone.2017.04.015","article-title":"A cumulative analogue joint involvement scale (CAJIS) for fibrodysplasia ossificans progressiva (FOP)","volume":"101","author":"Kaplan","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bone.2022.116642_bb0115","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s11136-013-0581-8","article-title":"Development of the PROMIS\u00ae pediatric global health (PGH-7) measure","volume":"23","author":"Forrest","year":"2014","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.bone.2022.116642_bb0120","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","article-title":"Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items","volume":"18","author":"Hays","year":"2009","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.bone.2022.116642_bb0125","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.paid.2006.09.017","article-title":"Understanding the limitations of global fit assessment in structural equation modeling","volume":"42","author":"Steiger","year":"2007","journal-title":"Personal. Individ. Differ."},{"key":"10.1016\/j.bone.2022.116642_bb0130","series-title":"Evaluating Cutoff Criteria of Model Fit Indices for Latent Variable Models With Binary and Continuous Outcomes","author":"Yu","year":"2002"},{"key":"10.1016\/j.bone.2022.116642_bb0135","series-title":"Mplus User\u2019s Guide","author":"Muth\u00e9n","year":"2004"},{"key":"10.1016\/j.bone.2022.116642_bb0140","series-title":"Encyclopedia of Quality of Life and Well-Being Research","first-page":"1675","article-title":"Divergent validity","author":"Hubley","year":"2014"},{"key":"10.1016\/j.bone.2022.116642_bb0145","series-title":"Reliability and Validity (Including Responsiveness)","author":"Hays","year":"2005"},{"key":"10.1016\/j.bone.2022.116642_bb0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","article-title":"Quality criteria were proposed for measurement properties of health status questionnaires","volume":"60","author":"Terwee","year":"2007","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.bone.2022.116642_bb0155","series-title":"Psychometric Theory","author":"Nunnally","year":"1994"},{"key":"10.1016\/j.bone.2022.116642_bb0160","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02310555","article-title":"Coefficient alpha and the internal structure of tests","volume":"16","author":"Cronbach","year":"1951","journal-title":"Psychometrika"},{"key":"10.1016\/j.bone.2022.116642_bb0165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12891-019-2761-3","article-title":"Determining known-group validity and test-retest reliability in the PEQ (personalized exercise questionnaire)","volume":"20","author":"Rodrigues","year":"2019","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.bone.2022.116642_bb0170","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.bone.2022.116642_bb0175","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3758\/BRM.42.3.871","article-title":"Estimating confidence intervals for eigenvalues in exploratory factor analysis","volume":"42","author":"Larsen","year":"2010","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.bone.2022.116642_bb0180","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.gim.2022.08.013","article-title":"The natural history of fibrodysplasia ossificans progressiva: a prospective, global 36-month study","volume":"24","author":"Pignolo","year":"2022","journal-title":"Genet. Med."},{"key":"10.1016\/j.bone.2022.116642_bb0185","series-title":"Guidance for Industry. Patient-reported Outcome Measures: Use in Medical Product Development to Support Labelling Claims","year":"2009"},{"key":"10.1016\/j.bone.2022.116642_bb0190","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/09638288.2017.1405083","article-title":"Longitudinal study of the activities of daily living and quality of life in japanese patients with fibrodysplasia ossificans progressiva","volume":"41","author":"Nakahara","year":"2019","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.bone.2022.116642_bb0195","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bone.2017.06.009","article-title":"Joint-specific risk of impaired function in fibrodysplasia ossificans progressiva (FOP)","volume":"109","author":"Pignolo","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bone.2022.116642_bb0200","article-title":"Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study","volume":"369","author":"Devji","year":"2020","journal-title":"BMJ"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328222003192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328222003192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:45:55Z","timestamp":1762659955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328222003192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":37,"alternative-id":["S8756328222003192"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2022.116642","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Fibrodysplasia Ossificans Progressiva Physical Function Questionnaire (FOP-PFQ): A patient-reported, disease-specific measure","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2022.116642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116642"}}